Venus Remedies Q2 net up 28.42 pc at Rs 15 cr
Venus Remedies today said its net profit increased by 28.42 per cent to Rs 15.09 crore for the quarter ended September 30, 2012 mainly on account of robust sales.
By PTI |
NEW DELHI: Drug firm Venus Remedies today said its net profit increased by 28.42 per cent to Rs 15.09 crore for the quarter ended September 30, 2012 mainly on account of robust sales.
The company had posted a net profit of Rs 11.75 crore for the quarter ended September 30, 2011, Venus Remedies said in a filing to BSE.
Total income from operations of the company also rose to Rs 110.81 crore for the quarter under consideration from Rs 96.11 crore for the corresponding period previous fiscal.
During the quarter, the company secured its first patent from Canada for novel antibiotic 'Vancoplus', Venus Remedies said.
The company has also launched its anti-arthritic pain product in India during the quarter, it added.
Venus Remedies has three manufacturing units in Panchkula, Baddi and Werne in Germany.
The company had posted a net profit of Rs 11.75 crore for the quarter ended September 30, 2011, Venus Remedies said in a filing to BSE.
Total income from operations of the company also rose to Rs 110.81 crore for the quarter under consideration from Rs 96.11 crore for the corresponding period previous fiscal.
During the quarter, the company secured its first patent from Canada for novel antibiotic 'Vancoplus', Venus Remedies said.
The company has also launched its anti-arthritic pain product in India during the quarter, it added.
Venus Remedies has three manufacturing units in Panchkula, Baddi and Werne in Germany.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
